rs144408326

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024570.4(RNASEH2B):​c.859G>T​(p.Ala287Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00147 in 1,603,568 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 16 hom. )

Consequence

RNASEH2B
NM_024570.4 missense

Scores

3
8
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 5.46

Publications

19 publications found
Variant links:
Genes affected
RNASEH2B (HGNC:25671): (ribonuclease H2 subunit B) RNase H2 is composed of a single catalytic subunit (A) and two non-catalytic subunits (B and C) and specifically degrades the RNA of RNA:DNA hybrids. The protein encoded by this gene is the non-catalytic B subunit of RNase H2, which is thought to play a role in DNA replication. Multiple transcript variants encoding different isoforms have been found for this gene. Defects in this gene are a cause of Aicardi-Goutieres syndrome type 2 (AGS2). [provided by RefSeq, Nov 2008]
RNASEH2B Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • RNASEH2B-related type 1 interferonopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Aicardi-Goutieres syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_024570.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0097846985).
BP6
Variant 13-50956394-G-T is Benign according to our data. Variant chr13-50956394-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 312334.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0017 (259/152154) while in subpopulation EAS AF = 0.0211 (109/5172). AF 95% confidence interval is 0.0179. There are 2 homozygotes in GnomAd4. There are 145 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024570.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNASEH2B
NM_024570.4
MANE Select
c.859G>Tp.Ala287Ser
missense
Exon 11 of 11NP_078846.2Q5TBB1-1
RNASEH2B
NM_001411023.1
c.742-3751G>T
intron
N/ANP_001397952.1A0A2R8Y883
RNASEH2B
NM_001142279.2
c.741+6889G>T
intron
N/ANP_001135751.1Q5TBB1-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNASEH2B
ENST00000336617.8
TSL:1 MANE Select
c.859G>Tp.Ala287Ser
missense
Exon 11 of 11ENSP00000337623.2Q5TBB1-1
RNASEH2B
ENST00000646960.1
c.859G>Tp.Ala287Ser
missense
Exon 11 of 13ENSP00000496481.1A0A2R8Y7R8
RNASEH2B
ENST00000643159.1
c.769G>Tp.Ala257Ser
missense
Exon 13 of 16ENSP00000495587.1A0A2R8YEH2

Frequencies

GnomAD3 genomes
AF:
0.00170
AC:
259
AN:
152038
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00400
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.0210
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000882
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00445
AC:
1054
AN:
236908
AF XY:
0.00393
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0144
Gnomad ASJ exome
AF:
0.000209
Gnomad EAS exome
AF:
0.0214
Gnomad FIN exome
AF:
0.00137
Gnomad NFE exome
AF:
0.00101
Gnomad OTH exome
AF:
0.00188
GnomAD4 exome
AF:
0.00144
AC:
2097
AN:
1451414
Hom.:
16
Cov.:
30
AF XY:
0.00140
AC XY:
1007
AN XY:
721350
show subpopulations
African (AFR)
AF:
0.0000602
AC:
2
AN:
33220
American (AMR)
AF:
0.0128
AC:
566
AN:
44094
Ashkenazi Jewish (ASJ)
AF:
0.000155
AC:
4
AN:
25726
East Asian (EAS)
AF:
0.0187
AC:
738
AN:
39452
South Asian (SAS)
AF:
0.00149
AC:
127
AN:
85186
European-Finnish (FIN)
AF:
0.00114
AC:
60
AN:
52752
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5750
European-Non Finnish (NFE)
AF:
0.000451
AC:
499
AN:
1105364
Other (OTH)
AF:
0.00159
AC:
95
AN:
59870
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
102
204
307
409
511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00170
AC:
259
AN:
152154
Hom.:
2
Cov.:
32
AF XY:
0.00195
AC XY:
145
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41502
American (AMR)
AF:
0.00399
AC:
61
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.0211
AC:
109
AN:
5172
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4822
European-Finnish (FIN)
AF:
0.000945
AC:
10
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000882
AC:
60
AN:
68008
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00172
Hom.:
5
Bravo
AF:
0.00242
Asia WGS
AF:
0.00895
AC:
31
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
Aicardi-Goutieres syndrome 2 (3)
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Pathogenic
0.16
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.53
D
Eigen
Uncertain
0.66
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.85
T
MetaRNN
Benign
0.0098
T
MetaSVM
Uncertain
0.58
D
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.5
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.0
N
REVEL
Uncertain
0.59
Sift
Benign
0.23
T
Sift4G
Benign
0.19
T
Varity_R
0.16
gMVP
0.34
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs144408326;
hg19: chr13-51530530;
COSMIC: COSV60746323;
COSMIC: COSV60746323;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.